American Renal Associates Holdings Inc (ARA) Return on Investment ROI from the third quarter of 2020 to third quarter of 2019 and for the year 2020, average high and low, overall ranking from Sep 30 2020 to Sep 30 2019 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
American Renal Associates Holdings Inc   (NYSE: ARA)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


American Renal Associates Holdings Inc's ROI from its third quarter of 2020 to the third quarter of 2019 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is American Renal Associates Holdings Inc's ROI in the third quarter of 2020?
American Renal Associates Holdings Inc achieved a return on average invested assets (ROI) of 3.99 % in its third quarter of 2020, which is below American Renal Associates Holdings Inc's average return on investment, which stands at 4.49%.

ROI decreased relative to the period ending Jun 30 2020, due to the decline in net income.

Within the Healthcare sector 144 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2020 from 559 to 1487.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter
Y / Y Investment Change TTM 20.07 % 19.82 % 26.97 % 25.62 % 13.13 %
Y / Y Net Income Change TTM 109.22 % - - - -
Investment (TTM) in Millions 909 721 921 896 746
Return On Investment (TTM) 3.99 % 4.71 % 3.49 % 3.32 % 2.29 %
ARA's Overall Ranking # 1487 # 559 # 876 # 1180 # 2255
Seq. Investment Change TTM 4.96 % -1 % 5.4 % 9.63 % 4.74 %
Seq. Net Income Change TTM -10.97 % 33.47 % 10.77 % 58.94 % -
Net Income (TTM) in Millions 34 39 29 26 16

ARA Company Profile >> Back to ARA Roi Comparisons >> See Annual ARA Return On Investment



Return On Investment ARA's Ranking
Within: No.
Industry # 18
Sector # 145
Overall # 1487

Return On Investment Statistics
High Average Low
9.5 %
4.49 %
0.44 %
(Mar 31 2018)   (Mar 31 2019)







Financial Statements
American Renal Associates Holdings Inc's III. Quarter Investments $ 909 Millions ARA's Balance sheet
American Renal Associates Holdings Inc's III. Quarter Income $ 13 Millions Quarterly ARA's Income Statement
ARA's Income by Division See ARA's Income by Division


ARA Annual Return On Investment (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2014)
2016
Total Investments in Millions 896 788 807 668 0
Y / Y Investment Growth 13.66 % -2.37 % 20.92 % - -
Net Income in Millions 26 22 76 82 0
Y / Y Net Income Growth 16.37 % -70.31 % -8.16 % - -
Annual Return On Investment 2.92 % 2.85 % 9.37 % 12.34 % -


Annual Roi Comment
In the fiscal year 2019 ROI improved to 2.92 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ARA's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ARA's Competitors
Subscribers only: Roi for American Renal Associates Holdings Inc's Suppliers
Subscribers only: Return On Investment for ARA's Customers

Other Ratios
ARA's Roa ARA's Inventory Turnover Ratio ARA's Growth Rates ARA's Dividend Statistics
ARA's Profitability Ratios ARA's Asset Turnover Ratio ARA's Dividend Growth
ARA's Roe ARA's Valuation Ratios ARA's Financial Strength Ratios ARA's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2020, within Healthcare Sector ROI
Nature s Sunshine Products inc   10.70 %
Procyon Corporation  10.69 %
Varian Medical Systems Inc   10.69 %
Haemonetics Corporation  10.50 %
Illumina Inc   9.98 %
Quest Diagnostics Inc  9.93 %
Biodelivery Sciences International Inc   9.75 %
Msa Safety Inc  9.56 %
Antares Pharma Inc   9.20 %
Agilent Technologies inc   9.20 %
Prestige Consumer Healthcare Inc   9.17 %
Neurocrine Biosciences Inc   9.11 %
Lemaitre Vascular Inc   8.98 %
Dexcom Inc   8.86 %
Universal Health Services Inc   8.69 %
China Health Industries Holdings Inc   8.60 %
Steris Plc  8.51 %
Neogen Corporation  8.33 %
Exelixis Inc   8.26 %
Ufp Technologies Inc   8.22 %
Elite Health Systems Inc   8.15 %
U S Physical Therapy Inc  7.87 %
Pra Health Sciences Inc   7.75 %
Acorda Therapeutics Inc   7.53 %
Phibro Animal Health Corporation  7.53 %
Emergent Biosolutions Inc   7.48 %
Abbvie Inc   7.41 %
Luna Innovations Inc  7.35 %
Revvity Inc  7.32 %
Bruker Corporation  7.22 %

Date modified: 2026-09-18T13:11:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.